Get Involved > Match Matty

Match Matty

Will you Match Matty's £500 donation to Kidscan and help us to boost childhood cancer research in his memory?

Match Matty

About Match Matty

In 2022, Kidscan ambassador Matty Hatton sadly passed away after a long battle with Medulloblastoma simply because current treatment options were not effective enough.

Matty was an inspirational young man and one of his last wishes was for his mum to close his bank account and make a donation to Kidscan to put towards life-saving research. In April this year Kidscan received a donation of £500 that will go directly towards increasing the number of new treatments for children like Matty.

At Kidscan, we believe no child should ever have to think about what happens after they gain their angel wings because every child diagnosed with cancer should have suitable treatments readily available to them. But sadly, over the last 20 years only 4 new treatments have been made available for childhood cancers. Instead children often rely on treatments such as chemotherapies that are designed for adults and are not always effective at treating childhood cancers. This can be because they are not targeted to children’s cancers or because using them would cause too much damage to children’s bodies.

That’s why we need your help. We want you to help us boost childhood cancer research by matching Matty’s donation. Whether you choose to fundraise £500 or make a one-off donation in Matty’s memory, you will be helping us to create a world where every child diagnosed with cancer can survive.

Matty's Story

In December 2016, Matty Hatton developed headaches with occasional sickness. After a visit to the GP and a CT scan he was diagnosed with Medulloblastoma, a rare brain tumour. Matty had surgery and over 14 months of treatment which included chemotherapy and radiotherapy. Although Matty rang the end of treatment bell, 6 months later Matty found out he had relapsed. After this, his first relapse, treatment initially appeared to work, but once again in 2020 Matty relapsed and needed further treatment.

Matty was an inspirational young man, a huge Leicester City supporter and all through his treatment he was dedicated to completing his GCSE’s. To keep Matty motivated during lockdown his aunty setup Letters from the Lockdown, a facebook page that asked people to write to Matty. The response was overwhelming and Matty received over 800 letters and postcards from people across the country including astronaut Tim Peake, Leicester City’s Jamie Vardy and Ant and Dec.

Alongside Letters from the Lockdown, Matty became a Kidscan ambassador and helped us by using his story to raise awareness of childhood cancer and the importance of research. Everyone who met Matty always commented on how inspiring he was.

Throughout lockdown Matty continued to receive treatment, but in February 2022, Letters from the Lockdown posted:

“It is with great sadness that we have to announce that Matty gained his angel-wings last night. He peacefully slipped away with us by his side . Obviously this leaves a gaping hole in our hearts but we wish to celebrate having Matty in our lives for the short time that we did . We love our boy so much and he was the best son / brother anyone could ask for. He will be Forever 17”

More about Matty

Thank you for your Support

Thank you to our supporters who have made a donation of £500 each to Match Matty! Be first to Match Matty, click the links above to fundraise or donate!

Where your money goes

In the UK, 20% of children diagnosed with Cancer will not survive because treatment options are limited. Of those who do survive over 60% will go on to develop life altering disabilities because the treatments used to “cure” cause lasting damage to their growing bodies.

With your donations, Kidscan invest in scientists across the UK, who are dedicated to finding new treatments and delivery methods designed to both improve survival rates and eliminate the damage that current treatments cause. Like the researchers at The University of Salford, who are developing new chemotherapies and looking at ways to encase them in a structure until they reach the cancer.

Newsletter Sign Up